Diabetes Associated Ophthalmic Treatment Market (By Application: Dry Eye Syndrome, Glaucoma, Eye Allergy & Infection, Diabetic Retinopathy, Diabetic associated Macular Degeneration, Uveitis, Cataract, Diabetic Macular Edema; By Type: Drugs, Devices; By End-use: Hospitals, Ophthalmic Centers, Ambulatory Surgical Centers) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 20212030

The global diabetes associated ophthalmic treatment market size is expected to be worth around US$ 50.7 billion by 2030, according to a new report by Vision Research Reports.

The global diabetes associated ophthalmic treatment market size was valued at US$ 28.2 billion in 2020 and is anticipated to grow at a CAGR of 7.5% during forecast period 2021 to 2030.

Report Coverage

Growth Factors

 The increasing prevalence of type II diabetes, geriatric population, and availability of early detection techniques are some of the factors driving the growth. This is coupled with technological advancements and increasing awareness of early diagnostics to help increase the success rate of the available treatment options. An increasing number of clinical trials to assess new drugs and devices for the prevention and management of these ophthalmic conditions are expected to fuel market growth in upcoming years.

 An increasing number of initiatives being undertaken by governments and nonprofit organizations to increase diabetes associated ophthalmic disease awareness is expected to boost the adoption of devices used for the treatment. Furthermore, WHO and IDF are working together to prevent and control diabetes and ensure good quality of life for people worldwide by providing accessible treatment facilities.

By Type Analysis

The drugs segment dominated the market for diabetes associated ophthalmic and accounted for the largest revenue share of 58.6% in 2020. The drug segment comprises anti-glaucoma drugs, anti-inflammatory drugs, anti-VEGF drugs, anti-allergy drugs, and others.

The devices segment is growing at a rapid pace accounted for a CAGR of 6.4% during the forecast period. The devices segment comprises refractive error surgical devices, glaucoma surgical devices, cataract surgical devices, vitreoretinal surgical devices, diagnostic devices, and visual aid devices.

By End-use Analysis

The hospital segment dominated the market for diabetes associated ophthalmic and accounted for the largest revenue share of 39.4% in 2020. An increasing number of hospital admissions of diabetes patients are boosting the demand for the segment, 

By Application Analysis

The diabetic retinopathy segment dominated the market for diabetes associated ophthalmic and accounted for the largest revenue share of around 26.0% in 2020. Diabetic retinopathy is considered a critical medical condition that impacts the eyes of the patient leading to vision loss.

increasing clinical trials for the approval of drugs used for the treatment of diabetic retinopathy is expected to boost the growth of the market for diabetes associated ophthalmic.

By Regional Analysis

North America dominated the diabetes associated ophthalmic treatment market and held the largest revenue share of 37.5% in 2020. The growth in the region is mainly attributed to factors such as robust healthcare infrastructure,

 In Asia Pacific, the market for diabetes associated ophthalmic is expected to witness the fastest growth rate during the forecast period. The growing ophthalmic disorders burden and rising consumer awareness are expected to drive the market for diabetes associated ophthalmic in the region.

Key Players

• Alcon

• Johnson & Johnson Services, Inc.

• Bausch Health

• F. Hoffmann-La Roche Ltd

• Allergan

• Bayer AG

• Santen Pharmaceutical Co. Ltd.

• Novartis AG

• Pfizer, Inc.

• Genentech, Inc.

• Carl Zeiss Meditec

• Lumenis

• Ellex Medical Lasers Ltd.

• IRIDEX Corp.

• Topcon Corp.

• Abbott Medical Optics

• Quantel

Market Segmentation

• By Application 

  • Dry Eye Syndrome

  • Glaucoma

  • Eye Allergy & Infection

  • Diabetic Retinopathy

  • Diabetic associated Macular Degeneration

  • Uveitis

  • Cataract

  • Diabetic Macular Edema

  • Others

• By Type 

  • Drugs

  • Devices

• By End-use 

  • Hospitals

  • Ophthalmic Centers

  • Ambulatory Surgical Centers

  • Others

• Regional

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

    • France

    • Italy

    • Spain

  • Asia Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

The Diabetes Associated Ophthalmic Treatment market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report provides size (in terms of volume and value) of Diabetes Associated Ophthalmic Treatment market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

This report focuses on the global Diabetes Associated Ophthalmic Treatment market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Diabetes Associated Ophthalmic Treatment market development in United States, Europe and China.

It is pertinent to consider that in a volatile global economy, we haven’t just conducted Diabetes Associated Ophthalmic Treatment market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.

In terms of production side, this report researches the Diabetes Associated Ophthalmic Treatment capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.

In terms of consumption side, this report focuses on the consumption of Diabetes Associated Ophthalmic Treatment by regions (countries) and application.

Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Diabetes Associated Ophthalmic Treatment market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Diabetes Associated Ophthalmic Treatment market companies.

Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Diabetes Associated Ophthalmic Treatment market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.

The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.

Overall, this is an in-depth research report specifically for the Diabetes Associated Ophthalmic Treatment industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.

Diabetes Associated Ophthalmic Treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Diabetes Associated Ophthalmic Treatment market.

Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Diabetes Associated Ophthalmic Treatment market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.

Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Diabetes Associated Ophthalmic Treatment market. These factors have benefited the growth of the global market for Diabetes Associated Ophthalmic Treatment. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.

New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Diabetes Associated Ophthalmic Treatment. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).

In this study, the years considered to estimate the market size of Diabetes Associated Ophthalmic Treatment are as follows:

• History Year: 2017-2020

• Base Year: 2021

• Forecast Year 2021 to 2030

Reasons to Purchase this Report:

- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

The study objectives of this report are:

• To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
• Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
• Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
• To define, describe and forecast the market by type, application and region.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
• To strategically profile the key players and comprehensively analyze their growth strategies.